Up-Regulation of Endothelial Nitric-Oxide Synthase by Endothelium-Derived Hyperpolarizing Factor Involves Mitogen-Activated Protein Kinase and Protein Kinase C Signaling Pathways

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 2, 2003, Pages 753-764

  Wang, Hong ^a,b   Lin, Li ^a   Jiang, Jiangang ^a   Wang, Yan ^a   Lu, Zai Ying ^a   Bradbury, J Alyce ^b   Lih, Fred Bjørn ^b   Wang, Dao Wen ^a   Zeldin, Darryl C ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 17 OCTADECYNOIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; APIGENIN; ARACHIDONIC ACID; ARGININE; CITRULLINE; CYTOCHROME P450; CYTOCHROME P450 102 F87V; CYTOCHROME P450 2C11; CYTOCHROME P450 2J2; CYTOCHROME P450 EPOXYGENASE; CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 OR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; THREONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL TONE; CATTLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GENE OVEREXPRESSION; MALE; NITRIC OXIDE SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL FACTORS; CATTLE; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN KINASE C; RATS; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 0142179148     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.052787     Document Type: Article

References (52)

1. Aoyagi M, Arvai AS, Tainer JA, and Getzoff ED (2003) Structural basis for endothelial nitric oxide synthase binding to calmodulin. EMBO (Eur Mol Biol Organ) J 22:766-775.
2. Auricchio A, Hildinger M, O'Connor E, Gao GP, and Wilson JM (2001) Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 12:71-76.
3. Azuma H, Ishikawa M, and Sekizaki S (1986) Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88:411-415.
4. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, and Busse R (1996) Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94:3341-3347.
5. Butt E, Bernhardt M, Smonlenski A, Kotsonis P, Frohlich LG, Sickmann A, Meyer HE, Lohmann SM, and Schmidt HW (2000) Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem 275:5179-5187.
6. Cannon RO (1998) Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 44:1809-1819.
7. Capdevila JH, Falck JR, and Estabrook RW (1992a) Cytochrome P450 and the arachidonate cascade. FASEB J 6:731-736.
8. Capdevila JH, Wei S, Yan J, Karara A, Jacobson HR, Falck JR, Guengerich FP, and DuBois RN (1992b) Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 267:21720-21726.
9. Chen JK, Falck JR, Reddy KM, Capdevila J, and Harris RC (1998) Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelia cells. J Biol Chem 273:29254-29261.
10. Chen JK, Wang DW, Falck JR, Capdevila JH, and Harris RC (1999a) Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor. J Biol Chem 274:4764-4769.
11. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE (1999b) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289.
12. Cohen RA and Vanhoutte PM (1995) Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 92:3337-3349.
13. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, and Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Investig 96:60-68.
14. Fang X, Kaduce TL, Weintraub NL, Harmon S, Teesch LM, Morisseau C, Thompson DA, Hammock BD, and Spector AA (2001) Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem 276:14867-14874.
15. Fisslthaler B, Poop R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature (Lond) 401:493-497.
16. Fitzpatrick FA and Murphy RC (1988) Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase" -derived eicosanoids. Pharmacol Rev 40:229-241.
17. 2+/calmodulin dependent endothelial nitric oxide synthase activity. Circ Res 88:e68-e75.
18. Fleming I, Fisslthaler B, Michaelis UR, Kiss L, Popp R, and Busse R (2001b) The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells. Pflueg Arch 442:511-518.
19. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, and Michelson AD (1997) Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Investig 100:350-356.
20. Fulco AJ (1991) P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. Annu Rev Pharmacol Toxicol 31:177-203.
21. Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 288:373-376.
22. Garcia-Cardena G, Fan R, Stern DF, Liu J, and Sessa WC (1996) Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 271:27237-27240.
23. Gebremedhin D, Harder DR, Pratt PF, and Campbell WB (1998) Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res 35:274-284.
24. Graham-Lorence S, Truan G, Peterson JA, Falck JR, Wei S, Helvig C, and Capdevila JH (1997) An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S, 15R)-arachidonic acid epoxygenase. J Biol Chem 272:1127-1135.
25. Harder DR, Campbell WB, and Roman RJ (1995) Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 32:79-92.
26. Helvig C and Capdevila JH (2000) Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains. Biochemistry 39:5196-5205.
27. Jeremy JY, Rowe D, Emsley AM, and Newby AC (1999) Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 43:580-594.
28. Kilpatrick EV and Cocks TM (1994) Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br J Pharmacol 112:557-565.
29. Loscalzo J (2001) Nitric oxide insufficiency, platelet activation and arterial thrombosis. Circ Res 88:756-762.
30. Lu T, Katakam PV, VanRollins M, Weintraub NL, Spector AA, and Lee HC (2001) Dihydroxyeicosatrienoic acids are potent activators of Ca(2+)-activated K(+) channels in isolated rat coronary arterial myocytes. J Physiol (Lond) 534:651-667.
31. 2+-calmodulin. Biochemistry 35:14651-14658.
32. Michell BJ, Chen Z, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, and Kemp BE (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625-17628.
33. Moncada S and Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012.
34. Najibi S and Cohen RA (1995) Enhanced role of K+ channels in relaxations of hypercholesterolemic rabbit carotid artery to NO. Am J Physiol 269:H805-H811.
35. Node K, Huo Y, Ruan XL, Yang BC, Spiecker M, Ley K, Zeldin DC, and Liao JK (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science (Wash DC) 285:1276-1279.
36. s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 276:15983-15989.
37. Oltman CL, Weintraub NL, VanRollins M, and Dellsperger KC (1998) Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 83:932-939.
38. Palmer RM, Ferrige AG, and Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (Lond) 327:524-526.
39. Peng HB, Libby P, and Liao JK (1995) Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 270:14214-14219.
40. Pfister SL, Falck JR, and Campbell WB (1991) Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am J Physiol 261:H843-H852.
41. Pritchard KA, Wong PY, and Stemerman MB (1990) Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products. Am J Pathol 136:1383-1391.
42. Qu W, Rippe RA, Ma J, Scarborough P, Biagini C, Fiedorek FT, Travlos GS, Parker C, and Zeldin DC (1998) Nutritional status modulates rat liver cytochrome P450 arachidonic acid metabolism. Mol Pharmacol 54:504-513.
43. Quilley J, Fulton D, and McGiff JC (1997) Hyperpolarizing factors. Biochem Pharmacol 54:1059-1070.
44. Ramasamy S, Parthasarathy S, and Harrison DG (1998) Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid. J Lipid Res 89:268-276.
45. Rzigalinski BA, Willoughby KA, Hoffman SW, Falck JR, and Ellis EF (1999) Calcium influx factor, further evidence it is 5,6-epoxyeicosatrienoic acid. J Biol Chem 274:175-182.
46. Vallance P, Collier JG, and Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 21:997-1000.
47. Wu S, Moomaw CR, Tomer KB, Falck JR, and Zeldin DC (1996) Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460-3468.
48. Xiao X, Li J, and Samulski RJ (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70:8098-8108.
49. Xiao X, Li J, and Samulski RJ (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper virus. J Virol 72:2224-2232.
50. Zeldin DC (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276:36059-36062.
51. Zeldin DC, Kobayashi J, Falck JR, Winder BS, Hammock BD, Snapper JR, and Capdevila JH (1993) Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem 268:6402-6407.
52. Zheng J, Bird IM, Melsaether AN, and Magness RR (1999) Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140:1399-1407.